IQVIA
IQV
#811
Rank
โ‚ฌ25.02 B
Marketcap
147,45ย โ‚ฌ
Share price
2.64%
Change (1 day)
-9.71%
Change (1 year)

Revenue for IQVIA (IQV)

Revenue in 2025 (TTM): โ‚ฌ14.15 Billion

According to IQVIA's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.10 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ14.80 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IQVIA from 2012 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ13.88 B-6.21%
2024 โ‚ฌ14.80 B9.22%
2023 โ‚ฌ13.55 B0.9%
2022 โ‚ฌ13.43 B9.66%
2021 โ‚ฌ12.25 B32.66%
2020 โ‚ฌ9.23 B-6.7%
2019 โ‚ฌ9.89 B8.75%
2018 โ‚ฌ9.10 B11.91%
2017 โ‚ฌ8.13 B24.37%
2016 โ‚ฌ6.53 B24.61%
2015 โ‚ฌ5.24 B16.89%
2014 โ‚ฌ4.48 B21.58%
2013 โ‚ฌ3.69 B0.39%
2012 โ‚ฌ3.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚ฌ0.12 B-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA